Milagritos D Tapia

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. doi request reprint Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
    Milagritos D Tapia
    Centre pour le Développement des Vaccins, Bamako, Mali
    Vaccine 30:A79-85. 2012
  2. ncbi request reprint A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Am J Trop Med Hyg 73:26-31. 2005
  3. ncbi request reprint Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Pediatr Infect Dis J 25:819-25. 2006
  4. pmc Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali
    Julia Hütter
    Center for Vaccine Development and the Departments of Pediatrics and Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Am J Trop Med Hyg 86:1026-31. 2012
  5. ncbi request reprint Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali, Bamako, Mali
    Am J Trop Med Hyg 80:1033-8. 2009
  6. ncbi request reprint Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali
    Pediatr Infect Dis J 24:533-7. 2005

Detail Information

Publications6

  1. doi request reprint Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
    Milagritos D Tapia
    Centre pour le Développement des Vaccins, Bamako, Mali
    Vaccine 30:A79-85. 2012
    ..PRV provides protection against severe-RVGE caused by diverse rotavirus genotypes, including those not contained in the vaccine...
  2. ncbi request reprint A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Am J Trop Med Hyg 73:26-31. 2005
    ..The early onset of the window of vulnerability in Kangaba infants likely reflects the changing ecology of measles in Africa. Ways to protect these vulnerable infants against measles must be devised...
  3. ncbi request reprint Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys
    Milagritos D Tapia
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Pediatr Infect Dis J 25:819-25. 2006
    ..Measurement of IgG tetanus antitoxin in oral fluid was investigated as a practical and noninvasive alternative to and correlate of serum antibodies...
  4. pmc Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali
    Julia Hütter
    Center for Vaccine Development and the Departments of Pediatrics and Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Am J Trop Med Hyg 86:1026-31. 2012
    ..0 μg/mL; a level that impedes Hib upper respiratory carriage, and may thereby diminish the Hib transmission to the unimmunized susceptible population (i.e., providing indirect protection)...
  5. ncbi request reprint Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali, Bamako, Mali
    Am J Trop Med Hyg 80:1033-8. 2009
    ..0 microg/mL. Introduction of Hib vaccine led to rises in anti-PRP seroprevalence, significant reductions in Hib disease, and all-cause hospitalizations, whereas S. pneumoniae disease remained unchanged...
  6. ncbi request reprint Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine
    Samba O Sow
    Centre pour le Développement des Vaccins, Mali CVD Mali
    Pediatr Infect Dis J 24:533-7. 2005
    ..Population-based, bacteriologically confirmed disease burden data aid decision makers in African countries pondering whether to introduce Haemophilus influenzae type b (Hib) immunization for infants...